| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |